Overview
RARE market data
Price History
RARE price chart · 1M
- O
- 14.44
- H
- 14.70
- L
- 14.08
- C
- 14.47
- Vol
- 223,449.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $14.44
- Previous Close
- $14.52
- Day High
- $14.70
- Day Low
- $14.08
- 52 Week High
- $39.38
- 52 Week Low
- $12.73
- 7 Day Return
- -5.52%
- 30 Day Return
- -2.79%
- 90 Day Return
- -58.25%
- 1 Year Return
- -52.08%
- Daily Notional Volume
- $3.2M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$5.83 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.35 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -81.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $12.73 – $39.89 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.5B · P/B 15.22 · P/S 2.09.
Company News
10 captured
Evercore ISI Group Maintains In-Line on Ultragenyx Pharmaceutical, Raises Price Target to $18Benzinga ·
Morgan Stanley Maintains Equal-Weight on Ultragenyx Pharmaceutical, Raises Price Target to $20Benzinga ·